Why is bioAffinity Technologies stock surging today?
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
bioAffinity Technologies Inc (BIAF)
Track today's live bioAffinity Technologies (BIAF) share price, performance and key data on this page with our current NASDAQ:BIAF stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the bioAffinity Technologies share price on the NASDAQ exchange. Use the dropdown to switch exchange for the BIAF share price, head to our technical summary section, which provides analysis on bioAffinity Technologies share price buy/sell indicators using real-time data (or discuss the bioAffinity Technologies (BIAF) stock price today with other investors in the bioAffinity Technologies NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:BIAF share price (ISIN: US09076W4069) to enhance your trading decisions with our free investment tools and resources.
What Is the bioAffinity Technologies Inc Share Price Today?
The bioAffinity Technologies share price today is 8.830.
What Is the Stock Symbol for bioAffinity Technologies Inc
The stock symbol (or 'ticker') for bioAffinity Technologies Inc is "BIAF."
What Stock Exchange Does bioAffinity Technologies Inc Trade On?
bioAffinity Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is bioAffinity Technologies Inc a Good Stock to Buy?
Determining whether bioAffinity Technologies (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:BIAF share price (ISIN: US09076W4069) to enhance your trading decisions with our free investment tools and resources.
What Is the bioAffinity Technologies Inc Share Price Today?
The bioAffinity Technologies share price today is 8.830.
What Is the Stock Symbol for bioAffinity Technologies Inc
The stock symbol (or 'ticker') for bioAffinity Technologies Inc is "BIAF."
What Stock Exchange Does bioAffinity Technologies Inc Trade On?
bioAffinity Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is bioAffinity Technologies Inc a Good Stock to Buy?
Determining whether bioAffinity Technologies (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
8.830
-6.440(-42.17%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.379
10.630
52 wk Range
4.560
202.500
BIAF is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.37910.630
52 wk Range
4.560202.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BIAF Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Why is bioAffinity Technologies stock surging today?
- Investing.com
Form 8K bioAffinity Technologies Inc For: 18 August- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
07/08/2026
EPS / Forecast
-9.60 / -31.50
Revenue / Forecast
1.51M / 1.7M
Compare BIAF to Peers and Sector
Metrics to compare | BIAF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIAFPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −2.3x | −0.4x | |
PEG Ratio | −0.01 | −0.05 | 0.00 | |
Price/Book | 2.2x | 2.4x | 2.6x | |
Price / LTM Sales | 1.4x | 15.4x | 3.0x | |
Upside (Analyst Target) | - | 96.0% | 49.0% | |
Fair Value Upside | Unlock | 0.4% | 6.5% | Unlock |
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the bioAffinity Technologies (NASDAQ: BIAF) Share Price Today?
The bioAffinity Technologies stock price today is 8.830 USD.
What Stock Exchange Does bioAffinity Technologies (BIAF) Trade On?
bioAffinity Technologies is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for bioAffinity Technologies?
The stock symbol (also called a 'ticker') for bioAffinity Technologies is "BIAF."
What Is the Current bioAffinity Technologies Market Capitalisation?
As of today, bioAffinity Technologies (NASDAQ: BIAF) market cap is 8.240M USD.
What Is bioAffinity Technologies's (BIAF) Earnings Per Share (TTM)?
The bioAffinity Technologies EPS is currently -59.695 (Trailing Twelve Months).
When Is the Next bioAffinity Technologies Earnings Date?
bioAffinity Technologies's next earnings report will be released on 18/11/2026.
Is BIAF a Buy or Sell From a Technical Analyst Perspective?
Based on today's bioAffinity Technologies moving averages and other technical indicators, the daily buy/sell signal for BIAF stock is Neutral.
How Many Times Has bioAffinity Technologies Stock Split?
bioAffinity Technologies has split 2 times. (See the BIAF stock split history page for full effective split date and price information.)
How Many Employees Does bioAffinity Technologies Have?
bioAffinity Technologies has 57 employees, based on their latest Companies House report.
What is the current trading status of bioAffinity Technologies (NASDAQ: BIAF)?
As of 08/09/2026, bioAffinity Technologies (BIAF) is trading at a share price of 8.830 USD, with a previous close of 15.270 USD. The stock has fluctuated within a day range of 8.379 USD to 10.630 USD, while its 52-week range spans from 4.560 USD to 202.500 USD.
What Is the BIAF Premarket Price?
BIAF's last pre-market stock price is 10.658 USD. The pre-market share volume is 240,610.000, and the stock has decreased by -4.612, or -30.200%.
What Is the BIAF After Hours Price?
BIAF's last after hours stock price is 11.310 USD, the stock has decreased by -3.960, or -25.930%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.